Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
If your goals shift, timing matters. Learn how to adjust spending and savings so your budget stays aligned with new targets.
18,573 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
States are unlocking church land for housing through by-right rules, aiming to speed up construction and boost afford...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
Anthropic is moving toward a public listing, with Amazon and Google as key backers. If the IPO hits a trillion-dollar...
OKX Europe’s chief warns the EU’s MiCA regime could force a majority of crypto exchanges to shut down as the July 1 d...
SpaceX wiped out most of its early IPO surge as trading shifted toward a new Nasdaq-100 opening. The stock is testing...
Rhythmic secures a $4 million seed round led by Dragonfly to embed stablecoins into consumer-brand ecosystems, pairin...
Nebius surges on a pair of cloud deals and a swelling backlog, but a late Q4 miss and execution doubts keep investors...
A Miami-based fintech has closed a $17 million Series A to speed fiat-to-stablecoin trades for businesses. The round ...
Investors debate whether will joby aviation stock can double in 2026 as the eVTOL pioneer nears regulatory milestones...
The June S&P 500 quarterly rebalance could see new entrants like Marvell Technology, Reddit, and a mortgage-focused s...
Japan grants regulatory approval for Ripple to launch RLUSD through SBI Group, signaling a turning point for major ri...